A report from the Innovation Economy Council, an industry coalition, argues that Canada's biomanufacturing strategy must look beyond vaccines and move into the even more important field cell and gene therapies. Federal support will be crucial to ensuring that these facilities are located in innovation centres across the country where they can thrive.